S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NASDAQ:CORTCorcept Therapeutics News Headlines

$13.70
+0.25 (+1.86 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$13.34
Now: $13.70
$13.79
50-Day Range
$13.51
MA: $16.00
$17.21
52-Week Range
$9.70
Now: $13.70
$18.52
Volume947,341 shs
Average Volume1.04 million shs
Market Capitalization$1.58 billion
P/E Ratio14.57
Dividend YieldN/A
Beta1.09

Headlines

Corcept Therapeutics (NASDAQ CORT) News Headlines

Source:
DateHeadline
Corcept Therapeutics (NASDAQ:CORT) Rating Lowered to Hold at Jefferies Financial GroupCorcept Therapeutics (NASDAQ:CORT) Rating Lowered to Hold at Jefferies Financial Group
marketbeat.com - August 5 at 7:10 AM
Stock Traders Buy High Volume of Call Options on Corcept Therapeutics (NASDAQ:CORT)Stock Traders Buy High Volume of Call Options on Corcept Therapeutics (NASDAQ:CORT)
americanbankingnews.com - August 13 at 10:26 PM
Corcept Therapeutics Incorporated (NASDAQ:CORT) Expected to Post Quarterly Sales of $92.04 MillionCorcept Therapeutics Incorporated (NASDAQ:CORT) Expected to Post Quarterly Sales of $92.04 Million
americanbankingnews.com - August 8 at 8:41 PM
Zacks: Analysts Expect Corcept Therapeutics Incorporated (NASDAQ:CORT) Will Announce Earnings of $0.20 Per ShareZacks: Analysts Expect Corcept Therapeutics Incorporated (NASDAQ:CORT) Will Announce Earnings of $0.20 Per Share
americanbankingnews.com - August 7 at 12:04 AM
Oversold Conditions For Corcept Therapeutics (CORT)Oversold Conditions For Corcept Therapeutics (CORT)
nasdaq.com - August 6 at 4:08 PM
Corcept Therapeutics (NASDAQ:CORT)  Shares Down 1.7% Corcept Therapeutics (NASDAQ:CORT) Shares Down 1.7%
americanbankingnews.com - August 6 at 1:56 PM
Corcept Therapeutics (NASDAQ:CORT) Shares Gap Down to $15.69Corcept Therapeutics (NASDAQ:CORT) Shares Gap Down to $15.69
americanbankingnews.com - August 5 at 10:01 PM
Corcept (CORT) Q2 Earnings Top Estimates, Revenues Miss MarkCorcept (CORT) Q2 Earnings Top Estimates, Revenues Miss Mark
finance.yahoo.com - August 5 at 7:48 PM
Shuman Glenn & Stecker Investigates Corcept Therapeutics, Inc.Shuman Glenn & Stecker Investigates Corcept Therapeutics, Inc.
finance.yahoo.com - August 5 at 7:48 PM
Corcept Therapeutics (NASDAQ:CORT) Downgraded to Hold at Jefferies Financial GroupCorcept Therapeutics (NASDAQ:CORT) Downgraded to Hold at Jefferies Financial Group
americanbankingnews.com - August 5 at 7:11 AM
Corcept Therapeutics Incorporated (CORT) Q2 2020 Earnings Call TranscriptCorcept Therapeutics Incorporated (CORT) Q2 2020 Earnings Call Transcript
fool.com - August 5 at 3:32 AM
Corcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateCorcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 4 at 11:46 PM
Corcept Therapeutics EPS beats by $0.01, misses on revenueCorcept Therapeutics EPS beats by $0.01, misses on revenue
seekingalpha.com - August 4 at 6:43 PM
Corcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateCorcept Therapeutics Announces Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 4 at 6:43 PM
Corcept Therapeutics Q2 Earnings PreviewCorcept Therapeutics Q2 Earnings Preview
seekingalpha.com - August 3 at 10:29 PM
Did Hedge Funds Make The Right Call On Corcept Therapeutics Incorporated (CORT)Did Hedge Funds Make The Right Call On Corcept Therapeutics Incorporated (CORT)
finance.yahoo.com - August 3 at 10:29 PM
Did Hedge Funds Make The Right Call On Corcept Therapeutics Incorporated (CORT) ?Did Hedge Funds Make The Right Call On Corcept Therapeutics Incorporated (CORT) ?
finance.yahoo.com - August 3 at 5:29 PM
What Kind Of Investors Own Most Of Corcept Therapeutics Incorporated (NASDAQ:CORT)?What Kind Of Investors Own Most Of Corcept Therapeutics Incorporated (NASDAQ:CORT)?
finance.yahoo.com - August 3 at 12:28 PM
Corcept Therapeutics (NASDAQ:CORT) Trading Down 7%Corcept Therapeutics (NASDAQ:CORT) Trading Down 7%
www.americanbankingnews.com - July 31 at 8:50 PM
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant in Patients with Cushings Syndrome of Adrenal OriginCorcept Therapeutics Initiates Phase 3 Trial of Relacorilant in Patients with Cushing's Syndrome of Adrenal Origin
www.marketwatch.com - July 30 at 6:22 PM
Corcept Therapeutics (CORT) Scheduled to Post Earnings on TuesdayCorcept Therapeutics (CORT) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - July 29 at 10:31 AM
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference CallCorcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
finance.yahoo.com - July 28 at 6:14 PM
Corcept launches 2nd late-stage study of relacorilant in cortisol disorderCorcept launches 2nd late-stage study of relacorilant in cortisol disorder
seekingalpha.com - July 28 at 1:14 PM
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant in Patients with Cushing’s Syndrome of Adrenal OriginCorcept Therapeutics Initiates Phase 3 Trial of Relacorilant in Patients with Cushing’s Syndrome of Adrenal Origin
finance.yahoo.com - July 28 at 1:14 PM
Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Average Recommendation of "Hold" by BrokeragesCorcept Therapeutics Incorporated (NASDAQ:CORT) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - July 25 at 5:16 PM
Corcept completes enrollment in mid-stage study of relacorilant in ovarian cancerCorcept completes enrollment in mid-stage study of relacorilant in ovarian cancer
seekingalpha.com - July 23 at 12:46 PM
Corcept Therapeutics Completes Enrollment in Controlled, Phase 2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Ovarian CancerCorcept Therapeutics Completes Enrollment in Controlled, Phase 2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Ovarian Cancer
finance.yahoo.com - July 23 at 12:46 PM
Here are two reasons why Corcept Therapeutics Inc (NAQ:CORT) could be a stock to watchHere are two reasons why Corcept Therapeutics Inc (NAQ:CORT) could be a stock to watch
uk.finance.yahoo.com - July 20 at 10:01 AM
Corcept Therapeutics: A Long-Term Hold Despite Short-Term Sales ThreatCorcept Therapeutics: A Long-Term Hold Despite Short-Term Sales Threat
seekingalpha.com - July 13 at 6:34 PM
Is Corcept Therapeutics Incorporateds(NASDAQ:CORT) Recent Stock Performance Tethered To Its Strong Fundamentals?Is Corcept Therapeutics Incorporated's(NASDAQ:CORT) Recent Stock Performance Tethered To Its Strong Fundamentals?
finance.yahoo.com - July 6 at 5:24 PM
Is Corcept Therapeutics Incorporated's(NASDAQ:CORT) Recent Stock Performance Tethered To Its Strong Fundamentals?Is Corcept Therapeutics Incorporated's(NASDAQ:CORT) Recent Stock Performance Tethered To Its Strong Fundamentals?
finance.yahoo.com - July 6 at 5:24 PM
Corcepts Phase 3 Trial, And Other News: The Good, Bad And Ugly Of BiopharmaCorcept's Phase 3 Trial, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - July 5 at 10:40 AM
How quality and momentum are powering Corcept Therapeutics Inc (NAQ:CORT)How quality and momentum are powering Corcept Therapeutics Inc (NAQ:CORT)
uk.finance.yahoo.com - July 2 at 8:19 AM
Corcept launches late-stage study of relacorilant in pancreatic cancerCorcept launches late-stage study of relacorilant in pancreatic cancer
seekingalpha.com - July 1 at 2:28 PM
Corcept Therapeutics initiates late-study for Relacorilant doublet therapy in pancreatic cancerCorcept Therapeutics initiates late-study for Relacorilant doublet therapy in pancreatic cancer
seekingalpha.com - July 1 at 2:28 PM
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic CancerCorcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
finance.yahoo.com - June 30 at 11:32 PM
Corcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic CancerCorcept Therapeutics Initiates Phase 3 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
finance.yahoo.com - June 30 at 6:29 PM
First Week of CORT February 2021 Options TradingFirst Week of CORT February 2021 Options Trading
www.nasdaq.com - June 22 at 1:25 PM
Hedge Funds Standing By Corcept Therapeutics Incorporated (CORT)Hedge Funds Standing By Corcept Therapeutics Incorporated (CORT)
finance.yahoo.com - June 19 at 2:15 PM
Are shares in Corcept Therapeutics Inc ready to fly?Are shares in Corcept Therapeutics Inc ready to fly?
uk.finance.yahoo.com - June 17 at 9:37 AM
Four reasons why the Corcept Therapeutics Inc (NAQ:CORT) share price could moveFour reasons why the Corcept Therapeutics Inc (NAQ:CORT) share price could move
uk.finance.yahoo.com - June 17 at 9:37 AM
Corcept Therapeutics to Present Data at the American Association of Cancer Research Annual MeetingCorcept Therapeutics to Present Data at the American Association of Cancer Research Annual Meeting
finance.yahoo.com - June 15 at 9:22 AM
Corcept Therapeutics Inc.Corcept Therapeutics Inc.
www.marketwatch.com - June 6 at 3:04 PM
Why Is Corcept (CORT) Up 8.2% Since Last Earnings Report?Why Is Corcept (CORT) Up 8.2% Since Last Earnings Report?
finance.yahoo.com - June 3 at 1:30 PM
Has Corcept Therapeutics (CORT) Outpaced Other Medical Stocks This Year?Has Corcept Therapeutics (CORT) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - June 3 at 1:30 PM
Why Corcept Therapeutics Inc is a mid-cap stock for contrarian investorsWhy Corcept Therapeutics Inc is a mid-cap stock for contrarian investors
uk.finance.yahoo.com - June 2 at 9:54 AM
What can we use to predict NAQ:CORTs share price direction?What can we use to predict NAQ:CORT's share price direction?
uk.finance.yahoo.com - May 18 at 10:28 AM
Should You Worry About Corcept Therapeutics Incorporateds (NASDAQ:CORT) CEO Pay?Should You Worry About Corcept Therapeutics Incorporated's (NASDAQ:CORT) CEO Pay?
finance.yahoo.com - May 18 at 10:28 AM
Should You Worry About Corcept Therapeutics Incorporated's (NASDAQ:CORT) CEO Pay?Should You Worry About Corcept Therapeutics Incorporated's (NASDAQ:CORT) CEO Pay?
finance.yahoo.com - May 18 at 10:28 AM
Corcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual MeetingCorcept Therapeutics to Present Data at the American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - May 14 at 7:19 PM
Should You Climb on Board the Corcept Therapeutics Train?Should You Climb on Board the Corcept Therapeutics Train?
finance.yahoo.com - May 12 at 8:05 AM
This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.